Efficacy and safety of add-on parsaclisib to ruxolitinib therapy in myelofibrosis patients with suboptimal response to ruxolitinib: Final results from a phase 2 study Meeting Abstract
| Authors: | Yacoub, A.; Borate, U.; Rampal, R. K.; Ali, H.; Wang, E.; Gerds, A. T.; Hobbs, G. S.; Kremyanskaya, M.; Winton, E.; O'Connell, C.; Goel, S.; Oh, S. T.; Schiller, G. J.; Assad, A.; Erickson-Viitanen, S.; Zhou, F.; Daver, N. |
| Abstract Title: | Efficacy and safety of add-on parsaclisib to ruxolitinib therapy in myelofibrosis patients with suboptimal response to ruxolitinib: Final results from a phase 2 study |
| Meeting Title: | 64th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 140 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2022 Dec 10-13 |
| Meeting Location: | New Orleans, LA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2022-11-15 |
| Start Page: | 579 |
| End Page: | 582 |
| Language: | English |
| ACCESSION: | WOS:000893223200236 |
| DOI: | 10.1182/blood-2022-160384 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract -- Source: Wos |
